Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.
Related Posts
Auto & Transport Roundup: Market Talk
Lufthansa, Allegiant Air and more in the latest Market Talks covering the Auto and Transport sector.
H&M to Miss Margin Target as Higher Costs Hurt Earnings
H&M won’t hit a key profitability target this year but said sales momentum picked up through July and August before accelerating further in September.
FTC to Sue Drug Managers Over Insulin Prices
Preparations to sue follow a two-year probe into whether the firms steer patients away from less-expensive medicines.